What’s going on with the Synairgen share price?

The Synairgen share price has been on a wild ride, but that could be about to change as the company’s Covid treatment progresses through trials.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Synairgen (LSE: SNG) share price has been on a rollercoaster ride this year. Year-to-date, the stock is up 5.5%. However, these numbers don’t tell the whole story.

In May, shares in the biotechnology company slumped by more than a third, falling from around 148p to a low of 98p.

After reaching this low, the stock quickly rallied, charging higher over the following weeks to top out at 176p at the beginning of June. Despite this volatility, shares in the company are still up nearly 400% over the past 12 months. 

Should you invest £1,000 in Kainos right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Kainos made the list?

See the 6 stocks

Since the beginning of June, the Synairgen share price has moved sideways. So the question is, what’s next for the stock? 

Company outlook

It’s impossible to predict the short-term movements of stocks. Still, in the long-term, equity prices should track underlying business performance. Therefore, if the firm’s operating performance improves, the Synairgen share price should follow suit. 

Currently, the firm’s future depends on the success of its inhaled formulation of interferon beta, which is being trialled as a potential treatment for coronavirus. The company’s treatment, SNG001, has shown to be effective in initial studies, but there’s still a way to go before full commercialisation. 

Towards the end of May, the company informed the market that trials of the SNG001 treatment had shown it to be effective against SARS-CoV-2 variants. Commenting on the trial results, Professor Sir Stephen Holgate, the founder of Synairgen, said the studies confirmed interferon’s impact on viruses, which is a positive development for the treatment and only adds to its appeal for healthcare professionals. 

SNG001 is currently undergoing testing in a phase III trial on hospitalised patients. The company expects to report the results of the trial in the second half of 2021. In the meantime, the Synairgen share price is likely to remain volatile.

While the company has reported positive trial results from its treatment up to this point, SNG001 will only make it to market if it passes the last hurdle with flying colours. Unfortunately, there’s no guarantee it will.

Synairgen share price: risky investment 

If the treatment doesn’t make it through the final testing stage, Synairgen could lose its flagship product. This would be a massive blow for the business and would undoubtedly negatively impact the stock. 

On the other hand, if the treatment does make it through the phase III trials, the sky’s the limit for the company. Testing of SNG001 has so far shown it to be effective against all types of respiratory viruses. As such, the potential market for this new treatment could be colossal. 

Overall, the recent trading activity in the Synairgen share price seems to reflect the market’s uncertain views. It seems some investors don’t believe in the company’s treatment. 

However, based on the positive test results so far, I think SNG001 could have potential. With that being the case, I’m willing to change my previously negative opinion of the stock.

As the firm pushes forward, I’d buy a small speculative position for my portfolio. 

Should you buy Kainos now?

Don’t make any big decisions yet.

Because Mark Rogers — The Motley Fool UK’s Director of Investing — has revealed 5 Shares for the Future of Energy.

And he believes they could bring spectacular returns over the next decade.

Since the war in Ukraine, nations everywhere are scrambling for energy independence, he says. Meanwhile, they’re hellbent on achieving net zero emissions. No guarantees, but history shows...

When such enormous changes hit a big industry, informed investors can potentially get rich.

So, with his new report, Mark’s aiming to put more investors in this enviable position.

Click the button below to find out how you can get your hands on the full report now, and as a thank you for your interest, we’ll send you one of the five picks — absolutely free!

Grab your FREE Energy recommendation now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

Is now a good time to start investing in the stock market?

Predicting what the stock market will do in the next few weeks and months is nearly impossible. But over the…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

£5,000 invested in Legal & General shares 10 years ago would have generated passive income of…

Legal & General shares are one of the highest-yielding in the FTSE 100. How much passive income could have been…

Read more »

Passive income text with pin graph chart on business table
Dividend Shares

3 world-class dividend stocks to consider for passive income

These three stocks could potentially help investors create a stable – and growing – stream of passive income in the…

Read more »

Group of young friends toasting each other with beers in a pub
Investing Articles

Diageo’s share price plunges 43% in 2 years! Time to consider buying the dip?

With sales falling, the Diageo share price is being hit hard. But with the shares now trading near 52-week lows,…

Read more »

Night Takeoff Of The American Space Shuttle
Investing Articles

The GGP share price skyrockets 100%+ in 2025 – Could this be the breakout stock of the year?

With the GGP share price more than doubling in four months, can Greatland Gold continue to thrive throughout the rest…

Read more »

Illustration of flames over a black background
Investing Articles

JD Sports’ share price soars 27% in just 3 weeks – is this the hottest stock to consider buying now?

The JD Sports share price is rising rapidly as management steers the business back on track. Can this upward momentum…

Read more »

Nottingham Giltbrook Exterior
Investing Articles

The Marks and Spencer share price stumbles on a cyberattack! Is it time to panic?

A disruptive cybersecurity breach has brought down Marks & Spencer’s online store, sending the share price tumbling. Should investors be…

Read more »

piggy bank, searching with binoculars
Investing Articles

Down 32%, this FTSE stock now has a 12% dividend yield!

With one of the highest yields in the FTSE 350, is this emerging markets investment firm a screaming passive income…

Read more »